TIMOTHY SARTORI: Open Payments
NPI 1497345946 · LA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 15 payments from 8 companies in 2025. Trend: 2023 $1,502 · 2024 $1,050 · 2025 $491
Food & beverage: $491
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $164 |
| LivaNova USA, Inc. | 1 | $60 |
| Neurocrine BioSciences, Inc. | 2 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: LYBALVI, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, INGREZZA, ABILIFY ASIMTUFII, FANAPT, INVEGA SUSTENNA, ARISTADA, CAPLYTA.
Industry payments across CA — which companies pay providers there.
